Acute leukaemia can progress rapidly, usually requiring immediate treatment. The two most common types of acute leukaemia are acute myeloid leukaemia (AML), most often diagnosed in older people, and acute lymphoblastic leukaemia (ALL) most often diagnosed in younger people.
Both chronic lymphocytic leukaemia (CLL) and chronic myeloid leukaemia (CML) are often picked up incidentally in primary care. This is because presentation of these diseases can be gradual, with most patients with CLL diagnosed after undergoing a routine blood test.
Our courses will support you to:
Increase your awareness of the symptoms and diagnosis of acute and chronic leukaemia
Understand the different presentations, referral and management of acute and chronic leukaemia
Confidently assess the need for urgent referrals in accordance with the NICE NG12 guidelines
Appropriately safety net patients
Increase your confidence in dealing with angry patients
Find out more:
Access GatewayC’s Acute Leukaemia – Early Diagnosis course here
Access GatewayC’s Chronic Leukaemia – Early Diagnosis course here
Tuesday 15th September 2020 It’s World Lymphoma Awareness Day. Why not increase your knowledge and complete our free online Lymphoma – Early Diagnosis course supported by Lymphoma Action? Lymphoma has many non-site specific symptoms and patients can often visit...
Potential pitfall: Faecal calprotectin testing is an incredibly sensitive investigation for detecting the presence of inflammation. It is raised in a wide variety of conditions including malignancy, inflammatory bowel disease and alcohol misuse. It is therefore not...
Thursday 11th June 2020 Breathlessness is one of the common symptoms that people experience at the end of their lives. However, determining whether a patient is entering the last few days of their life requires the GP to consider a range of factors. Before making this...
Friday 5th June 2020 The consequences of poor patient preparation for a suspected cancer referral pathway can be significant; impacting not only patient trust, but also the number of DNAs. A study funded by Cancer Research focused on ‘what good looks like’ at the...